How does MRK's 2024 EPS trend compare to industry peers?

Merck's (MRK) 2024 EPS of $6.74 is significantly higher than its industry peers, Pfizer (PFE), Johnson & Johnson (JNJ), and Bristol-Myers Squibb (BMY), with American Express (AXP) also having a higher EPS. Earlyworks (ELWS) has a negative EPS, indicating potential losses for the period:

|code|Ticker|Name|Date|Diluted EPS|market_code|
|---|---|---|---|---|---|
|JNJ|JNJ.N|Johnson & Johnson|20240331|1.34|169|
|AXP|AXP.N|American Express|20240331|3.33|169|
|MRK|MRK.N|Merck|20240331|1.87|169|
|PFE|PFE.N|Pfizer|20240331|0.55|169|
|BMY|BMY.N|Bristol-Myers Squibb|20240331|-5.89|169|
|JNJ|JNJ.N|Johnson & Johnson|20240630|1.93|169|
|AXP|AXP.N|American Express|20240630|4.15|169|
|MRK|MRK.N|Merck|20240630|2.14|169|
|PFE|PFE.N|Pfizer|20240630|0.01|169|
|BMY|BMY.N|Bristol-Myers Squibb|20240630|0.83|169|